 |
인쇄하기
취소
|
New diabetic drug ‘Forxiga’ approved for domestic market
Developed by BMS and Astrazeneca … the 9th approval in the world
(Yakup shinmoon)
New diabetic drug will be introduced in domestic market.
BMS Korea (President Jordan Tur) and Astrazeneca Korea (President Liz Chatwin) announced the approval of Forxiga (the name of ingredient is Dapagliflozin), a restrainer affiliation of SGLT-2 on 28th, November by MFDS.
Forxiga is operated independen...
(Yakup shinmoon)
New diabetic drug will be introduced in domestic market.
BMS Korea (President Jordan Tur) and Astrazeneca Korea (President Liz Chatwin) announced the approval of Forxiga (the name of ingredient is Dapagliflozin), a restrainer affiliation of SGLT-2 on 28th, November by MFDS.
Forxiga is operated independen...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.